Delivery Order SPE2DB20D3104-SPE2DB23FV8Y8
Award Date
9/12/23
Potential Completion Date
9/13/23
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This is a Firm Fixed Price Delivery Order with a completion date of March 2, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $13,427.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. It is a firm fixed-price delivery order contract with a completion date of May 22, 2023. The contract was issued without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,362.44, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat type 2 diabetes. The contract, which has a completion date of May 2, 2023, is a delivery order and is priced on a firm fixed-price basis. This award is not associated with any set-aside requirements, indicating full...
This federal contract award, valued at $3,004.84, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order to provide Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a firm fixed-price pricing type and an ultimate completion date of November 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $6,833.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for diabetes management. This is a firm fixed-price delivery order contract with a completion date of September 19, 2023. The award was made through full and open competition, with no set-aside designations. Amerisourcebergen Drug...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
This federal contract award, valued at $1,951.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of November 27, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating this was an open...
This federal contract award, valued at $6,819.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has a completion date of May 3, 2023 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award, valued at $3,245.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a pharmaceutical product used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2024. The contract was awarded on a full and open competition basis, with no set-aside designation....
This federal contract award, with a ceiling value of $4,786.79, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used for the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...